The obscure advisory committees at the heart of the U.S. drug pricing debate
CHICAGO (Reuters) – Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli…
Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva
NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine…
U.S. regulator approves Teva migraine drug, shares rise
(Reuters) – Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the…
Incredibles 2: Flashing lights in film may cause epileptic seizures
Disney Pixar has had to issue a warning to theatres showing its blockbuster film Incredibles 2, as flashing lights in…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to…